tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

FATE Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
3d ago
ADVM
ALLO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4d ago
ABIO
ALLO
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
20d ago
FATE
Intellia Therapeutics CFO Glenn Goddard to step down, Edward Dulac to succeed
PremiumThe Fly
Intellia Therapeutics CFO Glenn Goddard to step down, Edward Dulac to succeed
26d ago
FATE
NTLA
Fate Therapeutics upgraded to Overweight from Neutral at Piper Sandler
PremiumThe Fly
Fate Therapeutics upgraded to Overweight from Neutral at Piper Sandler
1M ago
FATE
Fate Therapeutics Announces CFO Change and Shareholder Approvals
PremiumCompany AnnouncementsFate Therapeutics Announces CFO Change and Shareholder Approvals
1M ago
8K
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2M ago
FATE
Fate Therapeutics CFO Resigns, CEO to Assume Role
PremiumCompany Announcements
Fate Therapeutics CFO Resigns, CEO to Assume Role
2M ago
8K
FATE
Fate Therapeutics CFO Dulac resigns
PremiumThe Fly
Fate Therapeutics CFO Dulac resigns
2M ago
FATE
Fate Therapeutics price target lowered to $5 from $7 at H.C. Wainwright
PremiumThe Fly
Fate Therapeutics price target lowered to $5 from $7 at H.C. Wainwright
2M ago
FATE
Fate Therapeutics’ Reporting Strategy: A Double-Edged Sword for Investor Confidence and Share Stability
PremiumCompany Announcements
Fate Therapeutics’ Reporting Strategy: A Double-Edged Sword for Investor Confidence and Share Stability
2M ago
FATE
Fate Therapeutics price target lowered to $4 from $7 at Piper Sandler
PremiumThe Fly
Fate Therapeutics price target lowered to $4 from $7 at Piper Sandler
2M ago
FATE
Fate Therapeutics price target lowered to $5 from $7 at Wedbush
PremiumThe FlyFate Therapeutics price target lowered to $5 from $7 at Wedbush
2M ago
FATE
Fate Therapeutics price target lowered to $9 from $11 at Canaccord
PremiumThe Fly
Fate Therapeutics price target lowered to $9 from $11 at Canaccord
2M ago
FATE
Fate Therapeutics reports Q1 EPS (47c), consensus (49c)
PremiumThe Fly
Fate Therapeutics reports Q1 EPS (47c), consensus (49c)
2M ago
FATE
Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
PremiumPress Releases
Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
2M ago
FATE
Fate Therapeutics Advances in Autoimmune and Cancer Therapies
PremiumCompany Announcements
Fate Therapeutics Advances in Autoimmune and Cancer Therapies
2M ago
8K
FATE
Fate Therapeutics announces first lupus patient treated in Phase 1 FT819 trial
PremiumThe Fly
Fate Therapeutics announces first lupus patient treated in Phase 1 FT819 trial
2M ago
FATE
Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
PremiumPress Releases
Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
2M ago
FATE
FATE Earnings this Week: How Will it Perform?
PremiumPre-EarningsFATE Earnings this Week: How Will it Perform?
3M ago
FATE
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
PremiumPress Releases
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
3M ago
FATE
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
PremiumPress Releases
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
3M ago
FATE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >